Description
Determination of mutations in the IDH2 gene is recommended for all patients with gliomas for tumor classification according to the WHO system for the subsequent possibility of therapy personalization.
Period of execution
Within 12 days. The specified time does not include the day of biomaterial collection
Biomaterial type
- Tissue sample
- Tissue sample in paraffin block